Literature DB >> 31631335

The impact of lung microbiota dysbiosis on inflammation.

Daping Yang1, Yingying Xing1, Xinyang Song2, Youcun Qian1,3.   

Abstract

Host-microbiota interaction plays fundamental roles in the homeostasis of mucosal immunity. Dysbiosis of intestinal microbiota has been demonstrated to participate in various immune responses and many multifactorial diseases. Study of intestinal microbiota has moved beyond the consequences of dysbiosis to the causal microbiota associated with diseases. However, studies of pulmonary microbiota and its dysbiosis are still in their infancy. Improvement of culture-dependent and -independent techniques has facilitated our understanding of lung microbiota that not only exists in healthy lung tissue but also exerts great impact on immune responses under both physiological and pathological conditions. In this review, we summarize recent progresses of lung microbiota dysbiosis and its impact on the local immune system that determines the balance of tolerance and inflammation. We discuss the causal roles of pulmonary dysbiosis under disease settings, and propose that the interaction between lung microbiota and host is critical for establishing the immune homeostasis in lung.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  dysbiosis; inflammation; lung; microbiota; pulmonary disease

Mesh:

Year:  2019        PMID: 31631335      PMCID: PMC6954700          DOI: 10.1111/imm.13139

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  105 in total

1.  Cd1d-dependent regulation of bacterial colonization in the intestine of mice.

Authors:  Edward E S Nieuwenhuis; Tetsuya Matsumoto; Dicky Lindenbergh; Rob Willemsen; Arthur Kaser; Ytje Simons-Oosterhuis; Sylvia Brugman; Keizo Yamaguchi; Hiroki Ishikawa; Yuji Aiba; Yasuhiro Koga; Janneke N Samsom; Kenshiro Oshima; Mami Kikuchi; Johanna C Escher; Masahira Hattori; Andrew B Onderdonk; Richard S Blumberg
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

2.  Farm-like indoor microbiota in non-farm homes protects children from asthma development.

Authors:  Erika von Mutius; Juha Pekkanen; Pirkka V Kirjavainen; Anne M Karvonen; Rachel I Adams; Martin Täubel; Marjut Roponen; Pauli Tuoresmäki; Georg Loss; Balamuralikrishna Jayaprakash; Martin Depner; Markus Johannes Ege; Harald Renz; Petra Ina Pfefferle; Bianca Schaub; Roger Lauener; Anne Hyvärinen; Rob Knight; Dick J J Heederik
Journal:  Nat Med       Date:  2019-06-17       Impact factor: 53.440

Review 3.  Role of the lung microbiome in HIV pathogenesis.

Authors:  Meera K Shenoy; Susan V Lynch
Journal:  Curr Opin HIV AIDS       Date:  2018-01       Impact factor: 4.283

4.  Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells.

Authors:  Allison W Roberts; Bettina L Lee; Jacques Deguine; Shinu John; Mark J Shlomchik; Gregory M Barton
Journal:  Immunity       Date:  2017-11-14       Impact factor: 31.745

5.  Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies.

Authors:  Koshika Yadava; Céline Pattaroni; Anke K Sichelstiel; Aurélien Trompette; Eva S Gollwitzer; Olawale Salami; Christophe von Garnier; Laurent P Nicod; Benjamin J Marsland
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

6.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

7.  Analysis of the lung microbiome in the "healthy" smoker and in COPD.

Authors:  John R Erb-Downward; Deborah L Thompson; Meilan K Han; Christine M Freeman; Lisa McCloskey; Lindsay A Schmidt; Vincent B Young; Galen B Toews; Jeffrey L Curtis; Baskaran Sundaram; Fernando J Martinez; Gary B Huffnagle
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

8.  Lung microbiota across age and disease stage in cystic fibrosis.

Authors:  Bryan Coburn; Pauline W Wang; Julio Diaz Caballero; Shawn T Clark; Vijaya Brahma; Sylva Donaldson; Yu Zhang; Anu Surendra; Yunchen Gong; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

9.  Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice.

Authors:  Laura A Hancock; Corinne E Hennessy; George M Solomon; Evgenia Dobrinskikh; Alani Estrella; Naoko Hara; David B Hill; William J Kissner; Matthew R Markovetz; Diane E Grove Villalon; Matthew E Voss; Guillermo J Tearney; Kate S Carroll; Yunlong Shi; Marvin I Schwarz; William R Thelin; Steven M Rowe; Ivana V Yang; Christopher M Evans; David A Schwartz
Journal:  Nat Commun       Date:  2018-12-18       Impact factor: 14.919

Review 10.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02
View more
  13 in total

Review 1.  Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.

Authors:  Elisavet Stavropoulou; Konstantia Kantartzi; Christina Tsigalou; Theocharis Konstantinidis; Chrissoula Voidarou; Theodoros Konstantinidis; Eugenia Bezirtzoglou
Journal:  Front Cell Infect Microbiol       Date:  2021-01-28       Impact factor: 6.073

Review 2.  Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants.

Authors:  Tong Sun; Haiyang Yu; Jianhua Fu
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

Review 3.  Leptin in the Respiratory Tract: Is There a Role in SARS-CoV-2 Infection?

Authors:  Andreina Bruno; Giuliana Ferrante; Serena Di Vincenzo; Elisabetta Pace; Stefania La Grutta
Journal:  Front Physiol       Date:  2021-12-22       Impact factor: 4.566

Review 4.  Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics.

Authors:  Allan Radaic; Sean Ganther; Pachiyappan Kamarajan; Jennifer Grandis; Sue S Yom; Yvonne L Kapila
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

Review 5.  Nutritional Support in Coronavirus 2019 Disease.

Authors:  Ewa Stachowska; Marcin Folwarski; Dominika Jamioł-Milc; Dominika Maciejewska; Karolina Skonieczna-Żydecka
Journal:  Medicina (Kaunas)       Date:  2020-06-12       Impact factor: 2.430

Review 6.  Perspectives on Probiotics and Bronchopulmonary Dysplasia.

Authors:  Kun Yang; Wenbin Dong
Journal:  Front Pediatr       Date:  2020-10-23       Impact factor: 3.418

7.  Multicenter analysis of sputum microbiota in tuberculosis patients.

Authors:  Claudia Sala; Andrej Benjak; Delia Goletti; Sayera Banu; Jesica Mazza-Stadler; Katia Jaton; Philippe Busso; Sille Remm; Marion Leleu; Jacques Rougemont; Fabrizio Palmieri; Gilda Cuzzi; Ornella Butera; Valentina Vanini; Senjuti Kabir; S M Mazidur Rahman; Laurent Nicod; Stewart T Cole
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

Review 8.  Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19.

Authors:  Taha Baghbani; Hossein Nikzad; Javid Azadbakht; Fatemeh Izadpanah; Hamed Haddad Kashani
Journal:  Microb Cell Fact       Date:  2020-11-26       Impact factor: 5.328

Review 9.  Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.

Authors:  Saroj Khatiwada; Astha Subedi
Journal:  Hum Microb J       Date:  2020-08-05

Review 10.  Airway Natural Killer Cells and Bacteria in Health and Disease.

Authors:  Maud Theresine; Neha D Patil; Jacques Zimmer
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.